Abstract | BACKGROUND & AIMS: METHODS: RESULTS: During hospitalization, the platelet count was measured above 330,000/μl and partial portal vein thrombosis was diagnosed by imaging studies. The thrombotic event was assumed to be associated with the romiplostim treatment for immune thrombocytopenic purpura via excessive elevation of platelet count. After anticoagulation with heparin and cessation of romiplostim treatment, complete recanalisation of the portal vein was achieved. CONCLUSIONS:
|
Authors | Georg Dultz, Bernd Kronenberger, Alireza Azizi, Ulrike Mihm, Thomas J Vogl, Ulrike Sarrazin, Christoph Sarrazin, Stefan Zeuzem, Wolf-Peter Hofmann |
Journal | Journal of hepatology
(J Hepatol)
Vol. 55
Issue 1
Pg. 229-32
(Jul 2011)
ISSN: 1600-0641 [Electronic] Netherlands |
PMID | 21310200
(Publication Type: Case Reports, Journal Article)
|
Copyright | Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Receptors, Fc
- Receptors, Thrombopoietin
- Recombinant Fusion Proteins
- Thrombopoietin
- romiplostim
|
Topics |
- Angiography, Digital Subtraction
- Female
- Hepatitis C, Chronic
(complications)
- Humans
- Liver Cirrhosis
(complications)
- Middle Aged
- Portal Vein
- Purpura, Thrombocytopenic, Idiopathic
(complications, drug therapy)
- Receptors, Fc
- Receptors, Thrombopoietin
(agonists)
- Recombinant Fusion Proteins
(adverse effects)
- Risk Factors
- Thrombopoietin
(adverse effects)
- Tomography, X-Ray Computed
- Venous Thrombosis
(diagnostic imaging, etiology)
|